In preparation of Phase II studies, Right Brain Bio signs Manufacturing Agreement with Suven Pharmaceuticals for RB-190 to Target the Root Cause of Parkinson’s Disease
WESTCHESTER COUNTY, N.Y. and MONMOUTH JUNCTION, N.J., March 11, 2025 /PRNewswire/ -- Right Brain Bio, a biotechnology company pioneering treatments for complex diseases, today announced a manufacturing agreement with Suven